Success Story: Advancing Early Disease Detection Through Nanotechnology: I-140 NIW Approval Secured for a Nepali Researcher
Client’s Testimonial:
"I would like to sincerely thank you for all the hard work and dedication you put into my case. Your effort and consistent support truly made a difference. Because of your efforts, my case was approved, and I am truly grateful for your support throughout the process. I deeply appreciate your professionalism and commitment throughout the process. I am very thankful for your guidance and assistance.”
On April 28th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the field of Nanotechnology (Approval Notice).
General Field: Nanotechnology
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Nepal
State of Residence at the Time of Filing: Texas
Approval Notice Date: April 28th, 2026
Processing Time: 10 months, 4 days (Premium Processing Requested)
Case Summary:
This case involved a Nepali researcher whose work focuses on nanopore-based single-molecule sensing and single-cell analysis for biomarker detection. His research supports early disease diagnosis, precision medicine, and targeted therapeutic strategies for serious diseases such as cancer. At the time of filing, the client was conducting nanotechnology research at a U.S. research institution.
A Record Built on Focused Scientific Innovation
The client’s record included 2 peer-reviewed journal articles, 4 conference abstracts, 1 granted patent, and 19 citations. One of his papers ranked among the top 10% most cited publications in its field for its publication year. His work had also been used by other researchers in nanopore sensing, biomolecular detection, and intracellular delivery.
Peer Reliance and Expert Recognition
Experts confirmed the value of the client’s nanotechnology research and its relevance to precision medicine.
One recommender noted:
“In total, [client]'s many achievements make it abundantly clear that he is a valued researcher in the United States and a vital contributor to the scientific community.”
This endorsement supported the petition’s argument that the client is well-positioned to continue advancing biomarker detection and healthcare innovation in the United States.
How We Presented the NIW Case
For the I-140 NIW petition, we demonstrated that the client’s proposed endeavor had substantial merit and national importance by connecting his work to early disease detection, precision medicine, and healthcare innovation. We also showed that he was well-positioned to advance the endeavor through his advanced training, current research employment, publication record, citation impact, patent, and documented use of his work by other researchers.
The I-140 NIW petition was approved on April 28th, 2026, after the case was upgraded to Premium Processing. This approval supports the client’s continued work in nanotechnology and healthcare innovation in the United States.